Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Nov 13, 2024 7:27am
26 Views
Post# 36309773

RE:Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏

RE:Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary đź‘Ź@Bob123 le clown remember 24-11-2023 low = 0.135 & 08-01-2024 high = 0.36 before the FDA V4.0 and Sales Now 4.0 Europe & Canada & Now @Bob123 CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI. With its new capabilities, Ventripoint 4.0 provides additional insights, including: 3D Tensors: Visualise the direction and magnitude of surface changes. 4D Motion: Simulate a dynamic heart model across the cardiac cycle. 3D Global Strain: Assess longitudinal, circumferential, and total surface area changes. 3D Heat Map: Visualise surface area changes in a new heat map view. 3D Segmentation: Access a detailed polar map for surface area change analysis. Dr. Adams is a visionary with Ventripoint I think they know more about the Ventripoint tech than the whiners on this board. Something could happen anytime real fast! FDA V4.0 and Sales at any time now & That V4.0 Europe V4.0 ok & Canada The BEST automation and analysis of the PLANET GEN3EHO https://ascendcv.com/ Seamless, flexible integration with heterogeneous AI, imaging and enterprise IT environments enables a best-of breed approach. Examples include: Us2.ai - Benefit from the the industry’s most sophisticated integration of Us2.ai. Us2.ai FDA-approved measurements feed ASE-validated suggested interpretations that can automatically complete the echo report Save time with single-click navigation to the automated measurement source frame 1-click sync to automated measurement frame Distinct review processes for FDA-cleared versus investigational measurements, enhancing compliance and clarity Automatic grouping of Us2.ai measurements accelerates the measurement review process Visual notification of user edits performed on Us2.ai measurements promotes transparency and traceability Engineered for seamless integration: Gen3Echo was designed with commitment to openness, seamlessly integrating with AI, ML, and advanced visualization software to foster innovation and collaboration. Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.
<< Previous
Bullboard Posts
Next >>